Vertex Pharmaceuticals Inc.

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease. Vertex has a robust pipeline of investigational small molecule medicines in other serious disease areas where it has deep insight into causal human biology. One of these pipeline programs is investigating potential medicines for the treatment of APOL1-mediated kidney diseases, including FSGS. In addition, Vertex has a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy, and type 1 diabetes mellitus. Vertex is consistently recognized as one of the industry's top places to work, including 10 consecutive years on Science magazine's Top Employers list and appearing in the top five on the 2019 Best Employers for Diversity list by Forbes. For more information, please visit www.vrtx.com